Citius Pharmaceuticals, Inc. (CTXR): EBITDA
Older than the company's other figures. The latest EBITDA is for the year ended 2017-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.
-$9.98M
Year ended 2017-09-30
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2017-09-30 | -$9.98M | n/m | 2019-12-16, From 2016-10-01 |
| 2016-09-30 | -$7.45M | n/m | 2018-12-11, From 2015-10-01 |
| 2015-09-30 | -$3.23M | n/a | 2017-12-13, From 2014-10-01 |